Citation

Kuroda S, Kobashi Y, Oi T, Kawabe K, Shiozawa F, Okumura-Kitajima L, Sugisaki-Kitano M, Io F, Yamamoto K, Kakinuma H.: Discovery of potent, low-absorbable sodium-dependent glucose cotransporter 1 (SGLT1) inhibitor SGL5213 for type 2 diabetes treatment. Bioorg Med Chem, Volume 27 (2), 2019

Authors

Io F, Kakinuma H., Kawabe K, Kobashi Y, Kuroda S, Oi T, Okumura-Kitajima L, Shiozawa F, Sugisaki-Kitano M, Yamamoto K

Journal

Bioorg Med Chem

Year

2019

DOI

10.1016/j.bmc.2018.12.015

PubMed

30579799

Machine-readable

REST APIRDF